LI-COR expansion offers early-phase cGMP services
LI-COR Biosciences has expanded its production facility to offer contract manufacturing for early-phase cGMP materials.
LI-COR Biosciences has expanded its production facility to offer contract manufacturing for early-phase cGMP materials.
Gerresheimer has agreed to sell its lab glassware business to a private equity investor, describing the deal as part of an effort to focus on delivery devices and pharmaceutical packaging.
Spanish API maker Suanfarma has acquired a stake in contract manufacturer and spray-drying specialist Idifarma, boosting its international presence.
Canada has approved Brenzys, its first biosimilar version of Amgen’s Enbrel (etanercept) made by Korean drugmaker Samsung Bioepis.